Pink October and Medical Cannabis: Science in Favor of Quality of Life
This Pink October, we explore the scientific evidence connecting medical cannabis to oncological treatment, highlighting its fundamental role in alleviating symptoms and promoting well-being and quality of life for breast cancer patients.
By Korasana LATAM
Pink October and Medical Cannabis: Science in Favor of Quality of Life
Pink October is a global movement for breast cancer awareness, focusing on the importance of early diagnosis and supporting those facing the disease. More than debating prevention, this month invites us to look at integrative care options that seek to restore dignity and quality of life to patients during their oncological journey. It is within this landscape of palliative care and support that Medical Cannabis has gained prominence in the scientific community.
The Role of Medical Cannabis in Oncology
Breast cancer treatment often involves aggressive therapies, such as chemotherapy, radiation, and surgery, which bring a series of debilitating side effects. Current scientific research does not point to cannabis as a cure for cancer, but rather as a powerful ally in symptom management, acting through the human body's Endocannabinoid System (ECS) to restore balance (homeostasis).
Scientific Evidence and Proven Benefits
Clinical studies and reviews published in renowned journals, such as the Journal of Pain and Symptom Management — including the systematic review Medical cannabis in palliative care: A systematic review of current evidence and the clinical trial by Johnson et al. (2010) on intractable cancer-related pain — and official reports by the National Academies of Sciences, Engineering, and Medicine, have consolidated the use of phytocannabinoids (like CBD and THC) in crucial areas of oncological support:
Nausea and Vomiting Control: One of the most well-documented and approved uses of cannabis in medicine is the treatment of chemotherapy-induced nausea and vomiting (CINV). Patients who do not respond well to traditional antiemetics often find significant relief with cannabinoid-based therapies.
Chronic and Neuropathic Pain Management: Pain is one of the most reported symptoms by oncology patients. CBD (Cannabidiol) has remarkable anti-inflammatory properties, while THC modulates pain signals in the central nervous system. Together, they offer an alternative or complement to opioid use, reducing the risk of addiction and severe adverse effects.
Improvement in Sleep Quality and Anxiety: The emotional weight of a breast cancer diagnosis generates high levels of stress, anxiety, and insomnia. Cannabinoid compounds have shown efficacy in reducing anxiety and promoting deeper, restorative sleep cycles, which are essential for the body's recovery.
Appetite Stimulation: Severe weight loss (cachexia) and lack of appetite are common during chemotherapy. Phytocannabinoids help stimulate neurological pathways associated with hunger, assisting patients in maintaining the nutrition necessary to withstand treatment.
Future Perspectives: Beyond Palliative Care
While the current focus is on quality of life, preclinical research (studies on cells and animal models) has been investigating the antitumor properties of cannabinoids. Isolated studies suggest that compounds like CBD can induce apoptosis (programmed cell death) in certain breast cancer cell lines and inhibit metastasis. However, the medical community emphasizes that more human clinical trials are needed before any definitive conclusions can be drawn.
A Commitment to Conscious Care
This Pink October, we reinforce that science-based information is the best tool for well-being. The inclusion of medical cannabis in a treatment plan should always be discussed and monitored by a medical specialist, ensuring correct dosages and safe interactions with other medications.
Supporting Pink October is also supporting the evolution of integrative medicine. By demystifying the use of medical cannabis, we open doors to more humane, empathetic care focused on what truly matters: the life and comfort of those fighting breast cancer.